Precision BioSciences, Inc. - Rasio total nilai perusahaan marang pendapatan DTIL

Logo perusahaan publik Precision BioSciences Inc. (DTIL)

High barriers to entry and patent protection create temporary challenges, however, the commercialization of the ARCUS platform will ensure long-term revenue growth for Precision BioSciences (DTIL). The shift in the EV/Sales ratio visualizes this balance, where the 3202.04 mark reflects the latest business valuation data. Stable demand for gene therapy gives the asset defensive qualities, isolating the company from global economic shocks.

Precision BioSciences (DTIL): Rasio nilai perusahaan marang pendapatan saka 23.11.2025 nganti 19.11.2026

precisionbiosciences.com - rincian analitis lan metrik utama (DTIL)

Pambiji fundamental perusahaan:DTIL, precisionbiosciences.com
Produk asil prodhuksi Precision BioSciences

For the high-tech Precision BioSciences (DTIL), with its academic focus and costly R&D development of the ARCUS platform, the enterprise value-to-revenue multiple serves as a filter for market optimism. This indicator aggregates market capitalization and net debt, comparing them against sales volume, which allows investors to recognize asset overvaluation in a timely manner and avoid critical drawdowns during a trend reversal.

Analisis pesaing

TEM (tempus.com) - Rasio nilai perusahaan marang pendapatan|qiagen.com (QGEN) - Rasio nilai perusahaan marang pendapatan|Ionis (IONS) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Repligen|Avidity (RNA) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales CRSP|Rasio total nilai perusahaan marang pendapatan GeneDx|Rasio nilai perusahaan marang pendapatan Ultragenyx RARE|Rasio total nilai perusahaan marang pendapatan Beam Therapeutics (BEAM)|SRPT: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Twist Bioscience|TXG (10x Genomics) - Nilai perusahaan marang pendapatan|Intellia Therapeutics, Inc. (NTLA) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Stoke Therapeutics Inc|BLFS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan WVE (Wave Life Sciences Corp)|Rasio total nilai perusahaan marang pendapatan Maze Therapeutics Corp|Sionna Therapeutics Inc - Nilai perusahaan marang pendapatan|PRME (primemedicine.com) - Nilai perusahaan marang volume dodolan|TSHA - Rasio nilai perusahaan marang pendapatan|QURE (uniQure) - Rasio nilai perusahaan marang pendapatan|MeiraGTx Corp (MGTX) - Rasio nilai perusahaan marang pendapatan|Regenxbio - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan solidbio.com|Multiplikator nilai perusahaan marang pendapatan ocugen.com OCGN|Multiplikator EV/Sales PACB|Benitec - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Design Therapeutics DSGN|Multiplikator EV/Sales Rocket Pharmaceuticals RCKT|Nilai perusahaan marang volume dodolan 4D Molecular Corp|LXEO: Rasio nilai perusahaan marang pendapatan|KRRO (Korro Bio, Inc) - Nilai perusahaan marang pendapatan|Editas Medicine (EDIT) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan Silence Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan PRQR (proqr.com)|Rasio nilai perusahaan marang pendapatan Codexis Bio (CDXS)|Multiplikator EV/Sales sangamo.com (SGMO)|Rasio nilai perusahaan marang pendapatan nautilus.bio NAUT|Rasio total nilai perusahaan marang pendapatan Metagenomi, Inc (MGX)|Generation Bio Co. - Multiplikator EV/Sales|BOLD: Rasio nilai perusahaan marang pendapatan|XCUR (Exicure, Inc.) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan IMNN|Rasio nilai perusahaan marang pendapatan RXi Pharmaceuticals|mustangbio.com (MBIO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan TransCode (RNAZ)|Bionano Genomics Inc. - Rasio nilai perusahaan marang pendapatan|Applied DNA Sciences - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan bluebirdbio.com (BLUE)|IPA - Rasio nilai perusahaan marang pendapatan|OMGA - Multiplikator EV/Sales|OMIC (Singular Genomics Systems, Inc.) - Nilai perusahaan marang pendapatan|Regulus Therapeutics Inc - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Syros Pharmaceuticals|Nilai perusahaan marang pendapatan Telesis Bio (TBIO)|Multiplikator EV/Sales TCON|UBX - Multiplikator nilai perusahaan marang pendapatan